|
Market Closed -
Nasdaq
21:00:00 03/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 461.26 USD | -0.90% |
|
+2.97% | +40.92% |
| 11-03 | Amgen Inc., Q3 2026 Earnings Call, Nov 03, 2026 | |
| 11-03 | Amgen posts higher-than-expected third quarter results, but shares dip | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 249B | |||||
| 1,255B | |||||
| 641B | |||||
| 505B | |||||
| 381B | |||||
| 357B |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
